0 CHECKOUT

PRODUCT FILTERS

REGION

213
138
137
115
115

COUNTRY

107
23
23
15
15

PRICE

56
256
431
1,122

PUBLISHED

246
298
540
1,122

PRODUCT TYPE

1,070
49
2
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023

"Pipeline analysis of spinal muscular atrophy (SMA) market report provides with comprehensive analysis of drugs in clinical trials for treatment for spinal muscular atrophy. The report provides insights...

Published:  October 2015
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  January 2016
Price:  From

Neuroprotection - Drugs, Markets and Companies

This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as neurodegenerative disorders because many...

Published:  January 2016
Price:  From

Huntington's Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual...

Published:  March 2015
Price:  From

Neurotech Industry 2015-2016 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System

Now in its 11th year, The Neurotechnology Industry 2015-2016 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide...

Published:  September 2015
Price:  From

CNS Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management, Anti-Psychotics, Anti-Depressants,...

Published:  February 2015
Price:  From

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating...

Published:  December 2015
Price:  From

Alzheimer'S Disease: Pharmacuetical Drugs Vs. Medicinal Plants - Markets, Competitors and Opportunities: 2015-2020 Analysis and Forecasts

The objective of this report is to provide a detailed analysis of Alzheimer’s disease (AD) and the pharmaceutical drugs and medicinal plants used to treat and prevent it. It also provides an overview...

Published:  July 2015
Price:  From

Specialty Drug Distribution Market Analysis (2015 - 2020): By Drug Type (Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Hemophilia); By Distribution (Retail, Home Health, Clinics, Pharmacies)

Specialty Drugs are used to treat chronic diseases such as Cancer, Multiple Sclerosis and Rheumatoid Arthritis. Specialty Drugs are injectable, oral or inhaled in nature which are prescribed by the...

Published:  June 2015
Price:  From

Global Duchenne Muscular Dystrophy Drugs Market 2015-2019

About Duchenne muscular dystrophy Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness....

Published:  August 2015
Price:  From

Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders, Product, by Medication

'Global Sleeping Aids Market Size, Share, Development, Growth and Demand Forecast to 2020 - Industry Insights by Sleep Disorders (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking...

Published:  October 2015
Price:  From

Epilepsy Drugs Market in Europe - Market Analysis 2015-2019

About epilepsy Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and...

Published:  September 2015
Price:  From

Global Migraine Drugs Market 2015-2019

About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound....

Published:  February 2015
Price:  From

Epilepsy Therapeutics Market in the APAC Region 2015-2019

About Epilepsy Therapeutics Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations...

Published:  December 2014
Price:  From

Inhaled CNS Therapeutics

Neurological disorders are highly prevalent worldwide And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden...

Published:  June 2014
Price:  From

Global Multiple Sclerosis Drugs Market 2014-2018

About Multiple Sclerosis and Disease Types Multiple sclerosis is a chronic, inflammatory medical condition that results in demyelination, axonal transection, and neurodegeneration. The myelin sheath...

Published:  August 2014
Price:  From

Global Huntington's Disease Therapeutics Market 2014-2018

About Huntington's Disease Huntington's disease is a progressive neurodegenerative disorder that can be inherited from one generation to another as an autosomal dominant trait. It arises due to genetically...

Published:  October 2014
Price:  From

Global Alzheimer's Drugs Market 2014-2018

Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65...

Published:  June 2014
Price:  From

Alzheimer's Disease Drug Pipeline, Diagnostics and Biomarkers: New Developments, Growth Areas and Opportunities

This report is a comprehensive analysis and market study of the drug development pipeline relating to Alzheimer's Disease, which has been analysed alongside commercially available or developmental minimally-invasive...

Published:  September 2014
Price:  From

CAS Benztropine mesylate World Consumption Report

This CAS Benztropine mesylate World Consumption Report provides data on the net consumption of CAS 132-17-2 - Benztropine mesylate Substance(s) in each of the countries listed. The Substance(s) covered...

Published:  February 2016
Price: 
Loading Indicator

Our Clients